Clinical studies recruiting near Montreal

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · CIUSSS de l'Est-de-l'Île-de-Montréal · Pfizer · NCT05020236 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-11026, Montreal, Quebec · Colorado Prevention Center · NCT06024746 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · University of Montreal Hospital · Joseph Broderick, MD · NCT07227246 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Centre Hospitalier de l'Université de Montréal · Pfizer · NCT07028853 Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors
Phase 1 · Hygea Medical Clinic · McGill University · NCT06753994 RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
NA · Research center of the Institut universitaire en santé menta · Ciusss de L'Est de l'Île de Montréal · NCT05704582 Evaluation of Cognitive Improvement After Bariatric Surgery Using a Virtual Reality Program and the Neuropsi Neuropsycho
NA · Faubert Lab · Hospital General de México Dr. Eduardo Liceaga · NCT07229924 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · McGill University Health Centre ( Site 0106) · Merck Sharp & Dohme LLC · NCT06136559 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · McGill University Health Centre · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0419) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · CIUSSSEMTL-Hopital Maisonneuve-Rosemont · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · The Montreal Children's Hospital of the MUHC · National Cancer Institute (NCI) · NCT05099003 A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Gestion clinique médicale l'Actuel ( Site 3303) · Merck Sharp & Dohme LLC · NCT07266831 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · CIUSSS de l'Est-de-l'Île-de-Montréal · Pfizer · NCT06758401 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · The Montreal Children's Hospital of the MUHC · National Cancer Institute (NCI) · NCT06172296 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · McGill University Health Centre · Vertex Pharmaceuticals Incorporated · NCT04786262 GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and S
NA · GMF Bordeaux-Cartierville · CHU de Quebec-Universite Laval · NCT04889794 IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Phase 1 · Jewish General Hospital · Iksuda Therapeutics Ltd. · NCT05365659 PulseSelect™ PFA Global Registry
Phase N/A · McGill University Health Centre (MUHC) · Medtronic Cardiac Ablation Solutions · NCT06393920 First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT07332455 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · McGill University Health Centre · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer
Phase 2 · Centre Hospitalier de l'Université de Montréal · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04989725 The DRAGON 2 Trial
NA · McGill University Health Center · Maastricht University · NCT05428735 Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer
Phase 2 · McGill University Health Centre- Cedars Cancer Centre · McGill University Health Centre/Research Institute of the Mc · NCT04249154 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
Phase 1 · McGill University Health Centre · TORL Biotherapeutics, LLC · NCT06005740 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Jewish General Hospital · Hoffmann-La Roche · NCT06793215 UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · Montréal Children's Hospital · The Hospital for Sick Children · NCT06560606

Look up another city

Look up another condition